Alembic Limited Launches Second 100-Day 'Saksham Niveshak' Campaign for Dividend Claims
Alembic Limited has initiated the Second 100-Day Campaign 'Saksham Niveshak' running from April 1 to July 9, 2026, to help shareholders claim unpaid dividends and update KYC details. The campaign was launched following a request from IEPFA and MCA dated March 27, 2026, with the objective of preventing dividend and share transfers to IEPFA. The company published regulatory disclosures and newspaper advertisements on April 17, 2026, in both English and Gujarati newspapers, with Company Secretary Keval Thakkar overseeing the compliance process.

*this image is generated using AI for illustrative purposes only.
Alembic Limited has announced the launch of the Second 100-Day Campaign "Saksham Niveshak" to facilitate dividend claims and KYC updates for shareholders. The company disclosed this initiative through newspaper advertisements published on April 17, 2026, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Campaign Overview
The campaign has been initiated following a request from the Investor Education and Protection Fund Authority (IEPFA) and Ministry of Corporate Affairs (MCA) dated March 27, 2026. The primary objective is to reach out to shareholders whose dividends remain unclaimed or unpaid, with emphasis on KYC updation and related compliance measures.
| Parameter: | Details |
|---|---|
| Campaign Period: | April 1, 2026 to July 9, 2026 |
| Duration: | 100 days |
| Objective: | Facilitate dividend claims and KYC updates |
| Target: | Shareholders with unclaimed/unpaid dividends |
Regulatory Disclosure and Documentation
The company has fulfilled its disclosure obligations by publishing notices in both English and vernacular language newspapers. The advertisements appeared in Indian Express (English Edition) and Financial Express (Gujarati Edition) on April 17, 2026. Company Secretary Keval Thakkar signed the regulatory filing and newspaper notices, which were submitted to BSE Limited and National Stock Exchange of India Limited.
| Compliance Detail: | Information |
|---|---|
| Publication Date: | April 17, 2026 |
| English Newspaper: | Indian Express |
| Vernacular Newspaper: | Financial Express (Gujarati Edition) |
| Signatory: | Keval Thakkar, Company Secretary |
Process for Different Share Holdings
The campaign accommodates shareholders holding securities in both physical and dematerialized forms:
Physical Share Holdings
Shareholders holding shares in physical form must submit applicable ISR forms along with supporting documents to the company's Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The RTA office is located at "Geetakunj", 1, Bhakti Nagar Society, Behind ABS Tower, Old Padra Road, Vadodara-390 015, Gujarat.
Dematerialized Share Holdings
Shareholders holding shares in demat form need to update their KYC and other details with their respective Depository Participants (DP).
| Share Form: | Action Required |
|---|---|
| Physical Form: | Submit ISR forms to RTA MUFG Intime India |
| Demat Form: | Update KYC with respective DP |
| Contact: | Tel: +91 265 3566768 |
| Email: | investor.helpdesk@in.mpms.mufg.com |
Shareholder Benefits and Compliance
The initiative aims to prevent shareholders' dividends and shares from being transferred to IEPFA by encouraging timely KYC updates and contact information maintenance. ISR form details are available on the company's website at alembiclimited.com under Investors section and on the RTA website at web.in.mpms.mufg.com/KYC-downloads.html.
The company encourages all shareholders to act promptly within the campaign period to safeguard their entitlements and ensure compliance with statutory requirements.
Historical Stock Returns for Alembic
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.52% | -5.65% | +6.27% | -11.24% | -16.17% | -27.58% |
What impact will successful dividend claim recoveries have on Alembic's cash flow and balance sheet in the upcoming quarters?
How might increased KYC compliance rates affect Alembic's shareholder communication effectiveness and future corporate governance ratings?
Will other pharmaceutical companies follow Alembic's proactive approach to IEPFA compliance, potentially setting a new industry standard?


































